Pre-emptive Treatment of HCV after Living Donor Liver Transplantation with Direct-Acting Antiviral Agents. [electronic resource]
Producer: 20190911Description: 1334-1342 p. digitalISSN:- 1873-4626
- Adult
- Aged
- Antiviral Agents -- therapeutic use
- Benzimidazoles -- therapeutic use
- Carbamates
- Drug Therapy, Combination
- Female
- Fluorenes -- therapeutic use
- Genotype
- Graft Survival
- Hepacivirus -- genetics
- Hepatitis C, Chronic -- prevention & control
- Humans
- Imidazoles -- therapeutic use
- Interferon alpha-2 -- therapeutic use
- Interferon-alpha -- therapeutic use
- Isoquinolines -- therapeutic use
- Liver Transplantation
- Living Donors
- Male
- Middle Aged
- Polyethylene Glycols -- therapeutic use
- Pyrrolidines
- Recombinant Proteins -- therapeutic use
- Retrospective Studies
- Secondary Prevention -- methods
- Sofosbuvir -- therapeutic use
- Sulfonamides -- therapeutic use
- Sustained Virologic Response
- Uridine Monophosphate -- analogs & derivatives
- Valine -- analogs & derivatives
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.